Intrepid Recovery Center Unveils Innovative Partial Hospitalization Program (PHP) in West Palm Beach, Florida

Intrepid Recovery Center’s Founder, John Nash Pakel, Champions the Next Phase in Addiction Treatment with the Introduction of PHP – Transforming Lives and Offering Hope for a Brighter Tomorrow.

WEST PALM BEACH, FL / ACCESSWIRE / November 29, 2023 / Intrepid Recovery Center, a leader in addiction treatment, is excited to announce the introduction of its Partial Hospitalization Program (PHP). This program represents the center’s expansion into comprehensive outpatient care, building on its five-year legacy of exceptional inpatient residential treatment.

Intrepid PHP Program
Intrepid PHP Main Entrance

A New Chapter in Outpatient Care

Chief Executive John Nash Pakel reflects on the center’s evolution, stating, “We’ve been focusing on inpatient residential care for about five years now and have used this time to really establish a novel approach to continued outpatient care.” The PHP program embodies this innovative approach, providing a structured yet flexible environment for those seeking recovery.

About Intrepid Recovery Center

Situated in the heart of South Florida, Intrepid Recovery Center, accredited by the Joint Commission, is renowned for its effective treatment methods and compassionate approach. The center’s team, including several alumni, brings a wealth of experience and empathy to their work, guiding clients towards lasting recovery.

Innovative PHP/IOP Program

The Partial Hospitalization and Intensive Outpatient Programs at Intrepid Recovery Center offer a staged approach to structured treatment which empowers clients to retake their lives but without burdening them with more than they can handle. Pakel says, “The goal is to get back to your lives, your families, your jobs, without drugs and alcohol. It takes time, but most things worth doing aren’t done quickly.” It includes individual and group therapy, medical and psychiatric care, and holistic wellness services. Tailored to meet each client’s unique needs, the program’s duration typically ranges from 30-60 days, focusing on personalized treatment plans for effective recovery outcomes.

Program Benefits

  • Comprehensive Care: The program offers a range of services and resources, including diverse therapies and activities like music therapy and acupuncture.
  • Support and Aftercare: Emphasizing community and peer support, the PHP program fosters relationships that are crucial for long-term sobriety.
  • Flexibility: Designed for those with work or family obligations, the program integrates treatment into clients’ daily lives.

Positive Feedback and Rewards

“The feedback we’ve already gotten has been tremendous, and the whole experience has been incredibly rewarding for our entire team,” adds Pakel, highlighting the program’s early success and its impact on the team.

Admissions and Contact Information

For more information about the Partial Hospitalization Program or to schedule a consultation, contact Intrepid Recovery Center at 866-871-5111 or visit www.intrepidrecovery.com.

Contact Information:

John Nash Pakel
Owner
j.nash@apexwellness.com
866-871-5111

SOURCE: Intrepid Recovery Center

View source version on accesswire.com:
https://www.accesswire.com/810557/intrepid-recovery-center-unveils-innovative-partial-hospitalization-program-php-in-west-palm-beach-florida

Staff

Recent Posts

Vor Bio Announces $55.6 Million Private Placement

Intend to announce updated clinical data from Phase 1/2 VBP301 trial of VCAR33ALLO in the…

26 minutes ago

Outlook Therapeutics® Reports Financial Results for Fiscal Year 2024 and Provides Corporate Update

LYTENAVA™ is the first and only approved ophthalmic formulation of bevacizumab for the treatment of…

26 minutes ago

WEED Inc. President and CEO Releases Letter to Shareholders

TUCSON, Ariz., Dec. 27, 2024 (GLOBE NEWSWIRE) -- via IBN – WEED Inc. (OTCQB: BUDZ), (“WEED,”…

27 minutes ago

Cara Therapeutics Announces Effective Date of 1-for-12 Reverse Stock Split

STAMFORD, Conn., Dec. 27, 2024 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA) (the “Company”),…

27 minutes ago

argenx Announces Approval of VYVDURA (efgartigimod alfa and hyaluronidase-qvfc) in Japan for Adults with Chronic Inflammatory Demyelinating Polyneuropathy

VYVDURA® now approved for at-home self-injection in Japan for both generalized myasthenia gravis and CIDP…

27 minutes ago

Park Ha Biological Technology Co., Ltd. Announces Pricing of $4.8 Million Initial Public Offering

Wuxi, China, Dec. 26, 2024 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (the…

27 minutes ago